Exosome-Based Treatment for Atherosclerosis.
Jeongyeon Heo1, Hara Kang1,2
1Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon 22012, Korea.
International Journal of Molecular Sciences
|January 21, 2022
Summary
Exosomes, tiny vesicles involved in cell communication, play a key role in atherosclerosis, an inflammatory blood vessel disease. Understanding exosome function is crucial for developing new atherosclerosis treatments.
Area of Science:
- Cardiovascular Biology
- Cellular and Molecular Medicine
- Biomedical Research
Background:
- Atherosclerosis is an inflammatory condition characterized by lipid buildup in blood vessels.
- Cell-to-cell communication is integral to the development of atherosclerosis.
- Exosomes are key mediators of intercellular communication, transferring molecules like RNA, DNA, and proteins.
Purpose of the Study:
- To review the role of exosomes in the pathogenesis of atherosclerosis.
- To explore the therapeutic potential of exosomes in treating atherosclerosis.
- To summarize current research on exosome-derived regulation and treatment of atherosclerosis.
Main Methods:
- Literature review of studies on exosome function in atherosclerosis.
- Analysis of research on exosomes derived from various cell types.
- Examination of exosome-based therapeutic strategies for atherosclerosis.
Main Results:
- Exosomes can both promote and inhibit atherosclerosis progression.
- Exosomes derived from different cells exhibit distinct roles in atherosclerosis.
- Exosome-based therapies show promise for atherosclerosis treatment.
Conclusions:
- Exosomes are significant players in atherosclerosis pathogenesis and progression.
- Targeting exosome-mediated intercellular communication offers novel therapeutic avenues for atherosclerosis.
- Further research into exosome biology is essential for advancing atherosclerosis treatment strategies.
Related Concept Videos
01:26Atherosclerosis III: Management
59
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
59
01:36Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
238
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
238